Skip to content
Biodatica
Start free

Investigator

Daniel Faden

MASSACHUSETTS EYE AND EAR INFIRMARY · funded by NCI, NIDCR

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$816k

Summed across those awards.

First award
Apr 1, 2021

Latest Jun 1, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Blood-based early detection of viral precancers

    $642k

    Jun 1, 2026NCIMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11340418 (opens the source filing in a new tab)

  2. K23

    Dissecting temporal and spatial dynamics of immunotherapy resistance

    $174k

    Apr 1, 2021NIDCRMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11060027 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources